📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Recordati

1.1 - Company Overview

Recordati Logo

Recordati

Headquarter: Italy
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of medications and treatment options across specialty and primary care, consumer healthcare, and rare diseases, focusing on the development and distribution of therapies.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Recordati

Endo Logo

Endo

HQ: Ireland Website
  • Description: Provider of branded and generic pharmaceuticals for patient care, offering affordable, high-quality generics and treatments for unmet pelvic health needs; supplies products tailored to Canadian and emerging markets, and engages in public policy advocacy to enhance patient access, alongside a UK tax strategy focused on compliance and responsible planning.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Endo company profile →
Dyax Logo

Dyax

HQ: United States Website
  • Description: Provider of biotherapeutics focused on the discovery, development and commercialization for unmet medical needs, with an emphasis on inflammatory and oncology indications; lead product DX-88 approved under the brand name KALBITOR (ecallantide) by the United States Food and Drug.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Dyax company profile →
Recursion Logo

Recursion

HQ: United States Website
  • Description: Provider of a machine learning-driven drug discovery platform (Recursion OS), digital chemistry tools (MatchMaker), and an on-premise supercomputer (BioHive-1) to map complex biology and rapidly advance potential therapeutics; also collaborates with Bayer, Roche & Genentech, NVIDIA, Tempus, and Enamine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Recursion company profile →
Woolsey Pharmaceuticals Logo

Woolsey Pharmaceuticals

HQ: United States Website
  • Description: Provider of investigational oral fasudil (BRAVYL) for indications including dementia-related wandering, Progressive Supranuclear Palsy, Corticobasal Syndrome, and Amyotrophic Lateral Sclerosis; conducts phase 2a studies (FOUND, REAL, ROCKIT-1) to evaluate efficacy, safety, and biomarkers; and maintains an expanded access policy for serious or life-threatening conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Woolsey Pharmaceuticals company profile →
GlycoEra Logo

GlycoEra

HQ: Switzerland Website
  • Description: Provider of extracellular protein degraders for autoimmune diseases, leveraging its CustomGlycan platform to design bi-functional biologics that selectively degrade circulating or membrane disease-causing proteins, such as autoantibodies, without broadly suppressing the immune system. Offerings include G-LyTACs, a custom glycan engineering platform, and protein degradation therapeutics with applications in oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GlycoEra company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Recordati

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Recordati

2.2 - Growth funds investing in similar companies to Recordati

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Recordati

4.2 - Public trading comparable groups for Recordati

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Recordati

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Recordati

What does Recordati do?

Recordati is a provider of medications and treatment options across specialty and primary care, consumer healthcare, and rare diseases, focusing on the development and distribution of therapies.

Who are Recordati's competitors?

Recordati's competitors and similar companies include Endo, Dyax, Recursion, Woolsey Pharmaceuticals, and GlycoEra.

Where is Recordati headquartered?

Recordati is headquartered in Italy.

How many employees does Recordati have?

Recordati has 1,000 employees 🔒.

When was Recordati founded?

Recordati was founded in 2010 🔒.

What sector and industry vertical is Recordati in?

Recordati is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Recordati

Who are the top strategic acquirers in Recordati's sector and industry

Top strategic M&A buyers and acquirers in Recordati's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Recordati?

Top strategic M&A buyers groups and sectors for Recordati include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Recordati's sector and industry vertical

Which are the top PE firms investing in Recordati's sector and industry vertical?

Top PE firms investing in Recordati's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Recordati's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Recordati's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Recordati's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Recordati include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Recordati's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Recordati?

The key public trading comparables and valuation benchmarks for Recordati include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Recordati for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Recordati with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Recordati's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Recordati with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Recordati's' sector and industry vertical?

Access recent funding rounds and capital raises in Recordati's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Recordati